Additionally, the N-terminal SRCR sequence of LOXL3 possesses deacetylase activity, which impedes differentiation mediated by STAT3in both normal and cancer cells by reducing STAT3 acetylation 33. The gene discussed is LOXL3; the disease is cancer.